| Net Cash Provided by (Used in) Operating Activities |
$278,604,000 |
USD |
137% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$114,181,000 |
USD |
-202% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$409,714,000 |
USD |
-202% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
120,000,000 |
shares |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
75,061,000 |
shares |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
|
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$254,101,000 |
USD |
40% |
Q3 2025 |
Q1 2026 |
| Payments to Acquire Property, Plant, and Equipment |
$45,302,000 |
USD |
27% |
Q3 2025 |
Q1 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,270,840,000 |
USD |
196% |
Q3 2025 |
Q1 2026 |
| Property, Plant and Equipment, Gross |
$1,905,824,000 |
USD |
15% |
Q2 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$13,682,000 |
USD |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
|
Q2 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$29,663,000 |
USD |
35% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$17,869,000 |
USD |
26% |
Q2 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$1,300,000 |
USD |
18% |
Q3 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
|
Q2 2025 |
FY 2025 |